The objective of this study was to assess the variability of readings made using the Tonovet® rebound tonometer for measurement of intraocular pressure (IOP) in the peripheral cornea and in angulated positions on the canine corneal surface. Forty-six client-owned dogs admitted for ophthalmic evaluation at the Queen’s Veterinary School Hospital, University of Cambridge were included in the study. IOP readings were taken at a variety of locations and using the tonometer at a number of different angles to the cornea: 1) Perpendicularly at center of the cornea (CC); 2) At the center of the cornea but with the tonometer positioned at four angles, and 3) At four different points on the peripheral cornea. All values were compared with the values recorded at the recommended CC position. IOP values were significantly underestimated in seven positions, with median and interquartile range from 12.1 ± 4 mmHg (nasal on periphery) to 15 ± 5 mmHg (laterally angled at center), varying between 0 mmHg to 2.9 mmHg from the CC value. While dorsally angled in the central cornea were not significantly different from those at CC (p = 0.09). Median values were lower for measurements in peripheral positions when compared to angled central positions. These results demonstrate that angling the tonometer or measuring in peripheral regions can result in small but statistically significant underestimation of IOP values.

Background: Working dogs, such as police dogs and guide dogs, have important roles in the contemporary society by performing specific and demanding jobs. Ocular health and the maintenance of good visual acuity are imperative to strong work performance and thus human safety. Aim: The aim of this study was to assess ophthalmic abnormalities and refractive errors in police and guide dogs in Brazil. Methods: A total of 71 dogs (141 eyes) were evaluated. Ten were guide dogs and 61 were police dogs. The work performance was assessed by a questionnaire to each dog’s handler/owner. All the dogs underwent a complete ocular examination, and abnormalities were classified by condition, if they were active or inactive and if they were located within the visual axis. In addition, 62 dogs were evaluated by streak retinoscopy for refractive errors. Results: Ophthalmic abnormalities were detected in 38 (54%) dogs, of which 23 were considered inherited, 25 were considered active, and 10 were located within the visual axis. Incipient cataracts were the most prevalent abnormality. No guide dog had an abnormality within the visual axis. The most common refractive error was myopia with the median and interquartile range of −0.75 ± 0.75 diopters; among these, police dogs had −1.0 ± 0.5 diopters, whereas guide dogs +0.38 ± 0.75 diopters. Police dogs tended to be slightly myopic and guide dogs were emmetropic. Conclusion: Despite finding a considerable number of ophthalmic abnormalities and refractive error, work performance was good with no signs of visual impairment in any dog. Regular ophthalmic examinations are advised for working dogs, and an exclusion of severely affected dogs from breeding programs is recommended. Keywords: Cataract, Emmetropia, Guide dogs, Myopia, Police dogs.

To evaluate corneal sensitivity by using the Cochet-Bonnet® esthesiometer in normal canine eyes at different time points following instillation of three different topical non-steroidal anti-inflammatory drugs (flurbiprofen sodium 0.03%, diclofenac sodium 0.1% and ketorolac tromethamine 0.5%) and benzalkonium chloride 0.01%. Six healthy mixed breed dogs from the same litter were used in two different stages. First, one drop of flurbiprofen sodium 0.03% and diclofenac sodium 0.1% in each eye; second, one drop of ketorolac tromethamine 0.5% and benzalkonium chloride 0.01% in each eye. Baseline esthesiometry was obtained before eye drop application and every 15 minutes thereafter until a total of 105 minutes of evaluation time. A one-week interval was allowed between the two treatment phases. Statistical analysis was used to compare means according to time of evaluation and drug used. Diclofenac sodium 0.1% decreased corneal sensitivity at 75 and 90 minutes (P > 0.015) with possible interference on neuronal nociceptive activity and analgesic effect while ketorolac tromethamine 0.5% did not show any variation for esthesiometry means along the evaluation. Flurbiprofen sodium 0.03% resulted in increased esthesiometry values 30 minutes after instillation (P > 0.013), increasing corneal sensitivity and possibly producing a greater irritant corneal effect over its analgesic properties. Benzalkonium chloride 0.01% significantly increased corneal sensitivity at 15 minutes of evaluation (P > 0.001), most likely resulting from its irritating effect. Esthesiometry did not allow a definite conclusion over the analgesic effect of the NSAIDs tested; however it was effective in detecting fluctuations in corneal sensitivity.

Objective To assess the efficacy of 0.1% oclacitinib as a single agent, and in combination with tacrolimus 0.01%, for the control of ophthalmic signs of keratoconjunctivitis sicca (KCS) in dogs. Animals studied Thirty‐two dogs (57 eyes) diagnosed with idiopathic KCS were included. Inclusion criteria were Schirmer Tear Test 1 (STT‐1) values <15 mm/min and concurrent clinical signs such as ocular hyperemia and discharge. Procedures The animals were submitted to a randomized, open‐label, 5‐week study and divided into 3 treatment groups treated with the following ophthalmic solutions: (a) 0.1% oclacitinib, (b) 0.1% oclacitinib +0.01% tacrolimus, and (c) 0.01% tacrolimus. Eye drops were instilled twice daily (12‐hour intervals). At each follow‐up examination, STT‐1, clinical signs, and potential drug side effects were assessed. Results Oclacitinib did not significantly improve STT‐1 values or clinical scores. Tacrolimus alone and in combination with oclacitinib increased mean STT‐1 values by 11.84 ± 5.2 and 12.46 ± 5.3 mm/min, respectively (P = 0.0001). Clinical scores of ocular discharge and hyperemia also improved significantly in both groups receiving treatment with tacrolimus (P < 0.05). However, addition of oclacitinib to tacrolimus provided no additional improvement over tacrolimus alone. Conclusions Topical 0.1% oclacitinib twice daily is not effective in controlling the ocular signs of KCS in dogs. 0.01% tacrolimus increased STT‐1 values significantly and could potentially be used as a treatment for mild‐to‐moderate cases of KCS. Synergism between drugs did not occur, and therefore the use of oclacitinib is not justified in cases of canine KCS.

An 8-yr old, neutered female Doberman Pinscher was presented for dermatological evaluation due to numerous pruritic, non-pigmented nodules that created a plaque in the lumbo-sacral region. This report is the first published photographic record of an acrochordonous plaque in a dolichocephalic dog and is the first reported case in Brazil.